Zhongwei Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhongwei Cheng has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Hua Deng
Department of Cardiology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China
3 shared publications- Deyan Yang
Department of Cardiology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China
2 shared publications Jingbo Fan
Department of Cardiology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China
2 shared publicationsJinzhi Lai
Department of Cardiology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China
2 shared publicationsKangan Cheng
Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
2 shared publicationsTaibo Chen
Department of Cardiology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China
2 shared publications
Latest Publications
- 7 November 2025
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 48 (12) , 1466-1476
Very‐Early Recurrence Burden of Atrial Tachyarrhythmias After Atrial Fibrillation Ablation Predicts Late Recurrence
Background: Very‐early recurrence of atrial tachyarrhythmia (VERAT) is common after atrial fibrillation (AF) radiofrequency ablation. The association between the burden of VERAT and late recurrence of atrial tachyarrhythmia (LRAT) has not been fully studied. Methods: Consecutive patients who underwent index AF ablation from September 1, 2020, to August 31, 2023, were enrolled. VERAT was defined as any recurrent atrial tachyarrhythmias within the first 7 days after ablation. All patients were followed up for 12 months. VERAT patients were classified into three groups by cutoff value based on receiver operating characteristic (ROC) curve analysis: without‐VERAT, low VERAT burden (< 18.17%), and high VERAT burden (≥ 18.17%). The association between VERAT burden and LRAT was analyzed by Cox regression model. Results: VERAT occurred in 137 of the 503 patients (27.2%). LRAT was observed in 53 patients (10.5%). VERAT burden was higher among LRAT patients. ROC curve revealed a correlation between VERAT burden and LRAT (area under curve 0.654, 95% confidence interval [95% CI] 0.566–0.741, p < 0.001). Compared with without‐VERAT group and low VERAT burden group, patients in high VERAT burden group were related to a 5.3‐fold (hazard ratio [HR] 5.307, 95% CI 2.909–9.683, p < 0.001) and 3.3‐fold (HR 3.276, 95% CI 1.471–7.293, p = 0.004) LRAT risk, respectively. Both VERAT (HR 3.001, 95% CI 1.748–5.154, p < 0.001) and VERAT burden (HR 1.024 per 1% increase, 95% CI 1.014–1.034, p < 0.001) were predictors of LRAT. Conclusion: VERAT and its burden were associated with an increased risk of LRAT in AF patients who underwent radiofrequency ablation.
- 7 November 2025
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 48 (12) , 1466-1476
Very‐Early Recurrence Burden of Atrial Tachyarrhythmias After Atrial Fibrillation Ablation Predicts Late Recurrence
Background: Very‐early recurrence of atrial tachyarrhythmia (VERAT) is common after atrial fibrillation (AF) radiofrequency ablation. The association between the burden of VERAT and late recurrence of atrial tachyarrhythmia (LRAT) has not been fully studied. Methods: Consecutive patients who underwent index AF ablation from September 1, 2020, to August 31, 2023, were enrolled. VERAT was defined as any recurrent atrial tachyarrhythmias within the first 7 days after ablation. All patients were followed up for 12 months. VERAT patients were classified into three groups by cutoff value based on receiver operating characteristic (ROC) curve analysis: without‐VERAT, low VERAT burden (< 18.17%), and high VERAT burden (≥ 18.17%). The association between VERAT burden and LRAT was analyzed by Cox regression model. Results: VERAT occurred in 137 of the 503 patients (27.2%). LRAT was observed in 53 patients (10.5%). VERAT burden was higher among LRAT patients. ROC curve revealed a correlation between VERAT burden and LRAT (area under curve 0.654, 95% confidence interval [95% CI] 0.566–0.741, p < 0.001). Compared with without‐VERAT group and low VERAT burden group, patients in high VERAT burden group were related to a 5.3‐fold (hazard ratio [HR] 5.307, 95% CI 2.909–9.683, p < 0.001) and 3.3‐fold (HR 3.276, 95% CI 1.471–7.293, p = 0.004) LRAT risk, respectively. Both VERAT (HR 3.001, 95% CI 1.748–5.154, p < 0.001) and VERAT burden (HR 1.024 per 1% increase, 95% CI 1.014–1.034, p < 0.001) were predictors of LRAT. Conclusion: VERAT and its burden were associated with an increased risk of LRAT in AF patients who underwent radiofrequency ablation.
- Open Access
- 5 February 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1336609
Case Report: Temporary pacing using active fixation lead and invasive electrophysiology studies for immune checkpoint inhibitor associated reversible advanced atrioventricular block
A case of immune checkpoint inhibitors (ICIs)-associated myocarditis with reversible advanced atrioventricular block (AVB) was reported. We innovatively used active fixation lead connected to an external device for prolonged temporary pacing until atrioventricular conduction recovered. Invasive electrophysiology studies were performed to evaluate atrioventricular conduction in detail. Long-term follow-up for nearly 120-days and repeated long-term electrocardiography was conducted to ensure the conduction system was truly recovered.
- 5 February 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1336609
Open AccessCase Report: Temporary pacing using active fixation lead and invasive electrophysiology studies for immune checkpoint inhibitor associated reversible advanced atrioventricular block
A case of immune checkpoint inhibitors (ICIs)-associated myocarditis with reversible advanced atrioventricular block (AVB) was reported. We innovatively used active fixation lead connected to an external device for prolonged temporary pacing until atrioventricular conduction recovered. Invasive electrophysiology studies were performed to evaluate atrioventricular conduction in detail. Long-term follow-up for nearly 120-days and repeated long-term electrocardiography was conducted to ensure the conduction system was truly recovered.
- Open Access
- 16 May 2022
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 66, 19-25
Relationship between the distribution of left atrial low-voltage zones and post-ablation atrial arrhythmia recurrence in patients with atrial fibrillation
- 16 May 2022
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 66, 19-25
Open AccessRelationship between the distribution of left atrial low-voltage zones and post-ablation atrial arrhythmia recurrence in patients with atrial fibrillation